Search alternatives:
groups decrease » groups decreased (Expand Search), group decreased (Expand Search)
marked decrease » marked increase (Expand Search)
groups decrease » groups decreased (Expand Search), group decreased (Expand Search)
marked decrease » marked increase (Expand Search)
-
1
-
2
-
3
-
4
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…*(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. P<sub>i</sub> group; <sup>#</sup>(P < 0.05) significant vs. …”
-
5
Altered expression of genes related to Ca<sup>2+</sup> cycling or myocardial contraction.
Published 2025Subjects: -
6
-
7
-
8
-
9
-
10
-
11
-
12
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…Summarized bar graphs showed EVO significantly decreased mRNA expression of pyroptotic markers (B) NLRP3 and (C) GSDM-D in CER treated P<sub>i</sub>-induced VSMCs. …”
-
13
-
14
-
15
-
16
-
17
(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.
Published 2025Subjects: -
18
-
19
Repetitive stress induces a decrease in sound-evoked activity.
Published 2025“…Activity rates decreased during repeated stress compared to baseline (2-way ANOVA, condition F = 49.6, <i>p</i> = 2.6 × 10<sup>−12</sup>, condition: intensity interaction F = 1.94, <i>p</i> = 0.02, nested ANOVA (mouse nested within session), F = 56.5, <i>p</i> = 8.8 × 10<sup>−14</sup>, condition: intensity interaction F = 3.5, <i>p</i> = 3.5 × 10<sup>−05</sup>). …”
-
20